Oxazolyl derivatives of formula (I) ##STR1## wherein --A.sup.1 .dbd.A.sup.2 --A.sup.3 .dbd.A.sup.4 -- represents a bivalent radical having the formula --CH.dbd.CH--CH.dbd.CH-- (a-1), --N.dbd.CH--CH.dbd.CH-- (a-2), --CH.dbd.N--CH.dbd.CH-- (a-3), --CH.dbd.CH--N.dbd.CH-- (a-4), --CH.dbd.CH--CH.dbd.N-- (a-5), --N.dbd.CH--N.dbd.CH-- (a-6) or --CH.dbd.N--CH.dbd.N-- (a-7); R represents hydrogen or C.sub.1-4 alkyl; R.sup.1 represents hydrogen, C.sub.1-6 alkyl or hydroxyC.sub.1-6 alkyl; m represents 1 or 2; D represents C.sub.1-4 alkanediyl; B represents NR.sup.2, CH.sub.2, O, S, SO or SO.sub.2 wherein R.sup.2 is hydrogen or C.sub.1-4 alkyl; n represents 0, 1 or 2; L represents hydrogen; C.sub.1-12 alkyl; C.sub.3-6 cycloalkyl; C.sub.3-6 alkenyl optionally substituted with aryl; C.sub.1-6 alkylcarbonyl; C.sub.1-6 alkyloxycarbonyl; arylcarbonyl; arylC.sub.1-6 alkyloxycarbonyl; or a radical of formula --Alk--R.sup.3 (b-1); --Alk--Y--R.sup.4 (b-2); --Alk--Z.sup.1 --C(.dbd.X)--Z.sup.2 --R.sup.5 (b-3); or --CH.sub.2 --CHOH--CH.sub.2 --O--R.sup.6 (b-4), the pharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof have antiallergic properties. Compositions containing the same and methods of treating warm-blooded animals suffering from allergic diseases.
式(I)的
噁唑基衍
生物##STR1##
其中--A.sup.1.dbd.A.sup.2--A.sup.3.dbd.A.sup.4--表示具有式--CH.dbd.CH--CH.dbd.CH--(a-1),--N.dbd.CH--CH.dbd.CH--(a-2),--CH.dbd.N--CH.dbd.CH--(a-3),--CH.dbd.CH--N.dbd.CH--(a-4),--CH.dbd.CH--CH.dbd.N--(a-5),--N.dbd.CH--N.dbd.CH--(a-6)或--CH.dbd.N--CH.dbd.N--(a-7)的二价基团;R表示氢或C.sub.1-4烷基;R.sup.1表示氢,C.sub.1-6烷基或羟基C.sub.1-6烷基;m表示1或2;D表示C.sub.1-4烷二基基;B表示NR.sup.2,CH.sub.2,O,S,SO或SO.sub.2,其中R.sup.2为氢或C.sub.1-4烷基;n表示0,1或2;L表示氢;C.sub.1-12烷基;C.sub.3-6环烷基;C.sub.3-6烯基可选地被芳基取代;C.sub.1-6烷基羰基;C.sub.1-6烷氧羰基;芳基羰基;芳基C.sub.1-6烷氧羰基;或式--Alk--R.sup.3(b-1)的基团;--Alk--Y--R.sup.4(b-2);--Alk--Z.sup.1--C(.dbd.X)--Z.sup.2--R.sup.5(b-3);或--CH.sub.2--CHOH--CH.sub.2--O--R.sup.6(b-4)的基团,其药学上可接受的酸加盐和立体
化学同分异构体具有抗过敏特性。含有它们的组合物以及治疗患有过敏性疾病的温血动物的方法。